Intellectual Property Litigation partner. Nicola’s practice spans four areas: (1) strategic life sciences patent and product lifecycle advice; (2) patent litigation; (3) co-ordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes. Nicola has tried over 20 cases.
Nicola has extensive experience in pharmaceutical and biologics patent litigation including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP litigation cases and drawing on more than 24 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global challenges.
Dagg, N., Lim, D., Baldwin, S., and Bornstein, G. (2020) “Trade Secrets 2020: Law and Practice”, Chambers and Partners Practice Guides
Dagg, N., Lim, D., Shandler, B., and Kritharidis, A. (2020) “Patent Litigation 2020: Trends and Developments”, Chambers and Partners Practice Guides